Section 335.9070  Training for the Oral Administration of Sodium Iodide I-131 Requiring a Written Directive in Quantities Greater Than 1.22 GBq (33 mCi)

Except as provided in Section 335.9160 of this Part, the licensee shall require the authorized user for the oral administration of sodium iodide I-131 requiring a written directive in quantities greater than 1.22 GBq (33 mCi) to be a physician who:

a)         Is certified by a medical specialty board whose certification process includes all of the requirements in subsection (c)(1) and (2) of this Section and whose certification has been recognized by the Agency, the U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State and who meets the requirements in subsection (c)(3) of this Section; or

AGENCY NOTE:  Specialty boards whose certification processes have been recognized by the Agency, the U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State will be posted on the NRC's Web page.

b)         Is an authorized user under Section 335.9050 of this Part for uses listed in Section 335.9050(b)(2)(F)(ii) of this Part, or equivalent U.S. Nuclear Regulatory Commission, Agreement State or Licensing State requirements; or

c)         Has:

1)         Successfully completed 80 hours of classroom and laboratory training applicable to the medical use of sodium iodide I-131 for procedures requiring a written directive.  The training shall include :

A)        Radiation physics and instrumentation;

B)        Radiation protection;

C)        Mathematics pertaining to the use and measurement of radioactivity;

D)        Chemistry of radioactive material for medical use;

E)         Radiation biology; and

2)         Work experience under the supervision of an authorized user who meets the requirements in this Section, Section 335.9050 of this Part, or equivalent U.S. Nuclear Regulatory Commission, Agreement State or Licensing State requirements.  A supervising authorized user who meets the requirements of Section 335.9050(b) of this Part shall have experience in administering dosages as specified in Section 335.9050(b)(2)(F)(ii) of this Part.  The work experience shall involve:

A)        Ordering, receiving and unpacking radioactive materials safely, and performing the related radiation monitoring;

B)        Performing quality control procedures on instruments used to determine the activity of dosages, and performing checks for proper operation of survey instruments;

C)        Calculating, measuring and safely preparing patient or human research subject dosages;

D)        Using administrative controls to prevent a medical event involving the use of radioactive material;

E)         Using procedures to contain spilled radioactive material safely and using proper decontamination procedures;

F)         Administering dosages to patients or human research subjects and shall include at least 3 cases involving the oral administration of greater than 1.22 GBq (33 mCi) of sodium iodide I-131; and

3)         Obtained written attestation that the individual has satisfactorily completed the requirements in subsections (c)(1) and (2) of this Section and has achieved a level of competency sufficient to function independently as an authorized user for the medical uses authorized under Section 335.5010 of this Part.  The written attestation shall be signed by a preceptor authorized user who meets the requirements in this Section, Section 335.9050 of this Part, or equivalent U.S. Nuclear Regulatory Commission, Agreement State or Licensing State requirements.  A preceptor authorized user who meets the requirements in Section 335.9050(b) of this Part must have experience in administering dosages as specified in Section 335.9050(b)(2)(F)(ii) of this Part.

(Source:  Amended at 32 Ill. Reg. 9247, effective June 13, 2008)